Clinical Trials Logo

Biliary Tract Cancer clinical trials

View clinical trials related to Biliary Tract Cancer.

Filter by:

NCT ID: NCT01171755 Terminated - Clinical trials for Biliary Tract Cancer

Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer

GetBil
Start date: February 2008
Phase: Phase 2
Study type: Interventional

In current study, we evaluate the efficacy of gemcitabine and TS-1 combination chemotherapy in advanced BTC.

NCT ID: NCT00955721 Terminated - Cholangiocarcinoma Clinical Trials

A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer

Start date: August 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to build on the efficacy of the GEMOX regimen by adding Sorafenib in the treatment of Biliary Tract Cancer. Since there is no data on the combination of these three agents, the investigators plan to evaluate the safety in a run-in phase I portion in order to define the recommended phase II dose (RPTD). The phase II trial will enroll 40 patients at the RPTD level within 2 years in order to provide a preliminary estimate of progression-free survival (primary endpoint of the trial) in the target population.

NCT ID: NCT00881504 Terminated - Clinical trials for Biliary Tract Cancer

A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma

Start date: June 2009
Phase: Phase 2
Study type: Interventional

This study is for patients with biliary tract cancer that has spread and who are not candidates for surgical resection. The purpose of this research is to determine if bevacizumab can be safely administered with Modified FOLFOX 6 and find out what effects, good and/or bad, this type of treatment has on biliary cancer. In this study, a combination of chemotherapy, Modified FOLFOX6 and a biologic agent, bevacizumab will be tested. Subjects on this study will receive chemotherapy and bevacizumab every 2 weeks until their disease gets worse or they are unable to tolerate treatment.

NCT ID: NCT00630890 Terminated - Cholangiocarcinoma Clinical Trials

Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)

Start date: October 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test the safety of giving external beam radiation, followed by a Cyberknife radiosurgery boost at different dose levels, together with a chemotherapy drug called capecitabine. The dose of Cyberknife radiosurgery boost will be made higher slowly in this protocol. Patients with hilar cholangiocarcinoma (Klatskin tumor), which is not amenable for surgical removal, are eligible. The hypothesis is that highly focused high dose radiation delivered using Cyberknife in conjunction with traditional radiation and chemotherapy can improve outcome in this patient population.

NCT ID: NCT00414843 Terminated - Cholangiocarcinoma Clinical Trials

Storage of Bile From Routine Procedures to Study Risk Factors

Start date: December 2006
Phase: N/A
Study type: Observational

The purpose of the study is to establish a repository of human bile as a resource for studies evaluating molecular predictors of biliary cancer risk.

NCT ID: NCT00090025 Terminated - Clinical trials for Biliary Tract Cancer

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Start date: September 2004
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to determine if XL119 is more effective than the combination of 5-fluorouracil (5FU) and leucovorin (LV) in prolonging the survival of subjects with advanced biliary tumors.